Oxygenation of the Cerebrum and Cooling During TAVI - Part I (OCCTAVI-I)

H

Hasselt University

Status and phase

Completed
Phase 3

Conditions

Neuroprotection
TAVI
Targeted Brain Cooling

Treatments

Device: nasopharyngeal targeted brain cooling

Study type

Interventional

Funder types

Other

Identifiers

NCT01759563
OCCTAVI-I
COBRA Research Group (Other Identifier)

Details and patient eligibility

About

Assessment of safety and feasibility of using a nasopharyngeal cooling technique to provide targeted brain cooling during percutaneous implantation of aortic valves. Was it possible to obtain brain temperatures below 34° within a reasonable time interval (max of 1hr) without delaying the procedure of valve implantation.

Full description

OCCTAVI-I Protocol 6 patients selected for Transcutaneous Aortic Valve Implantation (TAVI)-procedure will be subjected to intra-operative transnasal cooling (RhinoChill) ; cooling will be started after induction of anesthesia until tympanic temperature achieves 34° (cooling will be continued until 33°C of tympanic temperature, below 33°C active cooling will be stopped) No intra-aortic catheter will be inserted before tympanic temperature reaches 34° The aim of this study is to test the safety (as referring to routinely used neuromonitoring : ForeSight cerebral tissue oxygen saturation (SctO2) monitoring; and as referring to cardiovascular stability : blood pressure & heartrate) and feasibility (as referring to temperature characteristics) of brain cooling during TAVI (cerebral (or tympanic) cooling rate, differential tympanic-rectal cooling rate, rectal cooling rate, time needed to obtain tympanic temperature below 34°) Patients will be monitored with FORE-SIGHT cerebral oximeter (regional cerebral oxygen saturation, sensors placed on patient's forehead) and BIS VISTA (bilateral continuousEEG). Tympanic temperature will be measured every 5 minutes while oesophageal and blood temperature will be continuously measured. Neuromonitoring (Fore-Sight, Bispectral Index (BIS) Vista) will be started before induction of anesthesia and cooling Transnasal cooling will be started after induction of anesthesia until a target tympanic temperature of 34°C Core temperature will not be monitored by esophageal (caveat interaction TEE probe), but by rectal and blood temperature TAVI-procedure will be started at a tympanic temperature of 34°C Arterial CO2 tension (PaCO2) will be checked every 30 minutes intra-operatively (target=normocapnia) by arterial blood gas analysis to maintain strict normocapnia and the end of the TAVI-procedure, patient will be rewarmed at a max rate of 0.8°/h by total body bair hugger when patient reaches tympanic and systemic (rectal) temperature of 35.5°C, extubation can be performed

Enrollment

6 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pts eligible for TAVI interventions

Exclusion criteria

  • urgent intervention

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

6 participants in 1 patient group

single arm study
Other group
Treatment:
Device: nasopharyngeal targeted brain cooling

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems